Scientists report they have come up with a new treatment for children with brain tumors called medulloblastomas. Children with the high-risk tumors have a low 30-40 percent chance of surviving and living to the age of 5 and chemotherapy can take as long as a year.
But, Dr. Amar Gajjar of St. Jude’s Children’s Research Hospital in Memphis says using a patient’s own stem cells is having an amazing effect in treating the cancer.
Dr. Gajjar says, not only they can now cure about 70 percent of children with high-risk medulloblastoma, they can also cure more than 80 percent of those with standard-risk disease with a shorter, and therefore more convenient, chemotherapy approach.
The research team’s results appear in the latest issue of The Lancet Oncology.